Biocare Lifesciences Inc (BLI), a Philippines based pharmaceutical company who brought the brands of Remdesivir and Favipiravir in the country last year, announced the launched of the first branded generic of Tocilizumab (Temziva) 400mg/20mL Solution for infusion.
Temziva (Tocilizumab), a treatment known as an Interleukin-6 (IL-6) receptor blocker, has received approval from the Philippines Food and Drug Administration (FDA) to treat severe Covid-19 patients with Cytokine Release Syndrome.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.